Fundraising FoxLinearis Ventures
Venture capitalQuebec City · Seed–Series B · 3 people tracked
Find your way into Linearis Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Greg Rudin to introduce you to Alexandre Le Bouthillier
You →Greg · together at Creative Destruction Lab →Alexandre
Sign up to find every way you can get introduced to Linearis Ventures
- Your email: who you already know at Linearis Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Linearis Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Linearis combines a venture fund with a world-class metabolomics laboratory to invest in and support innovation across the AI-life science continuum. It backs companies advancing drug discovery, early diagnosis, disease prevention, and patient monitoring, aiming to prevent, detect, and cure diseases. Its tandem laboratory provides quantitative metabolomics analysis, disease-signature discovery, and AI analysis software to support portfolio companies and partners including BioPharma, CROs, biobanks, and clinical and academic institutions.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 3 of 3 portfolio companiesBiotech ×3AI & Machine Learning ×2Healthtech ×2Medical Devices ×2Deep Tech ×1Digital Health ×1
HQs:Canada×2United States×1
Investments · 3 tracked
founders shown can be your intro path
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.
BiotechDeep TechMedical Devices
François-Thomas Michaud(Board Member & Chief Executive Officer)in
Co-investorsAsahi Kasei Corporate Venture CapitalGenesys CapitalFonds de solidarité FTQZynext Ventures
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Jacob Rinaldi(Founder)inRonald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Co-Founder, CEO)inRon Alfa(Founder)Ron Alfa Jacob Rinaldi(Founder)
BoardJames Hardiman(Director)in
Co-investors11.2 CapitalBreakout LabsBreakout VenturesCatalio Capital Management, LPEPIC VENTURESIntermountain Health+6 more
Zilia develops a medical imaging platform that measures biomarkers in the eye to enable early detection of preventable blindness, including glaucoma and diabetic retinopathy.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesQuebec City, CA
Dr. Patrick Sauvageau(Co-founder)Dominic Sauvageau(Co-founder)in
Co-investorsAnges Québec
Portfolio news
latest coverage across their companiesFeldan Therapeutics · finsmes.com · Apr 17, 2025
Frequently asked questions
- What stage does Linearis Ventures invest at?
- Linearis Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Linearis Ventures focus on?
- Linearis Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Linearis Ventures located?
- Linearis Ventures is headquartered in Quebec City, CA.
- Who does Linearis Ventures co-invest with?
- Linearis Ventures most often shares deals with Breakout Ventures, Catalio Capital Management, LP, EPIC VENTURES, among 10 tracked co-investors.
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.